Loading organizations...
§ Private Profile · Mount Laurel, NJ, USA
Provides consultative analytics measuring pharmaceutical promotional effectiveness for pharma and biotech, focused on brand management.
ImpactRx, based in Mount Laurel, New Jersey, provides consultative analytics to measure pharmaceutical promotional effectiveness on physicians' prescribing behavior. The company tracks promotional initiatives using physician networks and data from longitudinal panels of over 4,000 targeted physicians. Its solutions encompass syndicated products for brand management, market research, sales, and oncology marketing, serving pharmaceutical and biotech firms. ImpactRx has attracted investment from firms including Mediphase Venture Partners, Oxford Bioscience Partners, and Merck Capital Ventures, and expanded its offerings through acquisitions such as Paragon Research & Consulting and TargetRx in 2011. The organization was founded in October 2000 by John Margraf, Gerry Gallivan, and Terry Overton. Its business model centers on private company funded by venture investors, generates revenue through syndicated data products, custom research, and analytics services sold to pharmaceutical and biotech firms.
ImpactRx has raised $1.2M across 1 funding round.
ImpactRx has raised $1.2M in total across 1 funding round.
ImpactRx has raised $1.2M in total across 1 funding round.
ImpactRx's investors include Mediphase Venture Partners, Merck Research Labs, Omega Funds, Oxford Bioscience Partners.
ImpactRx has raised $1.2M across 1 funding round. Most recently, it raised $1.2M Series E in January 2010.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 11, 2010 | $1.2M Series E | — | Mediphase Venture Partners, Merck Research Labs, Omega Funds, Oxford Bioscience Partners | Announced |